- Home
- AXSM vs LFUS Comparison
AXSM vs LFUS Comparison
Compare AXSM & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LFUS
- Stock Information
- Founded
- AXSM 2012
- LFUS 1927
- Country
- AXSM United States
- LFUS United States
- Employees
- AXSM N/A
- LFUS N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LFUS Electrical Products
- Sector
- AXSM Health Care
- LFUS Energy
- Exchange
- AXSM Nasdaq
- LFUS Nasdaq
- Market Cap
- AXSM 5.1B
- LFUS 5.7B
- IPO Year
- AXSM 2015
- LFUS N/A
- Fundamental
- Price
- AXSM $103.26
- LFUS $250.62
- Analyst Decision
- AXSM Strong Buy
- LFUS Buy
- Analyst Count
- AXSM 17
- LFUS 5
- Target Price
- AXSM $172.35
- LFUS $252.25
- AVG Volume (30 Days)
- AXSM 686.7K
- LFUS 203.8K
- Earning Date
- AXSM 08-04-2025
- LFUS 07-30-2025
- Dividend Yield
- AXSM N/A
- LFUS 1.20%
- EPS Growth
- AXSM N/A
- LFUS N/A
- EPS
- AXSM N/A
- LFUS 4.29
- Revenue
- AXSM $495,033,000.00
- LFUS $2,264,614,000.00
- Revenue This Year
- AXSM $61.62
- LFUS $6.40
- Revenue Next Year
- AXSM $59.02
- LFUS $7.76
- P/E Ratio
- AXSM N/A
- LFUS $58.25
- Revenue Growth
- AXSM 69.83
- LFUS 1.34
- 52 Week Low
- AXSM $75.56
- LFUS $142.10
- 52 Week High
- AXSM $139.13
- LFUS $275.56
- Technical
- Relative Strength Index (RSI)
- AXSM 46.21
- LFUS 61.96
- Support Level
- AXSM $96.09
- LFUS $245.84
- Resistance Level
- AXSM $109.88
- LFUS $258.53
- Average True Range (ATR)
- AXSM 4.46
- LFUS 7.21
- MACD
- AXSM -0.18
- LFUS 1.18
- Stochastic Oscillator
- AXSM 40.08
- LFUS 53.01
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LFUS Littelfuse Inc.
Littelfuse is a primary provider of circuit protection products (such as fuses and relays) into the transportation, industrial, telecommunications, and consumer electronics end markets. The firm is also increasing its power semiconductor business, where it predominantly serves industrial end markets and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.